The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR)

被引:0
|
作者
Khaled Nassar
Julia Lüke
Matthias Lüke
Mahmoud Kamal
Effat Abd El-Nabi
Mahmoud Soliman
Martin Rohrbach
Salvatore Grisanti
机构
[1] University of Lübeck,Department of Ophthalmology
[2] Fayoum University,Department of Ophthalmology
[3] Cairo University,Department of Ophthalmology
[4] Eberhard-Karls University,Centre for Ophthalmology
[5] University Eye Hospital,undefined
关键词
Proliferative vitreoretinopathy (PVR); Tractional retinal detachment (TRD); Trauma; Rabbits; Decorin; Vitrectomy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1649 / 1660
页数:11
相关论文
共 50 条
  • [21] SILICONE OIL IN AN EXPERIMENTAL-MODEL OF PROLIFERATIVE VITREORETINOPATHY (PVR)
    VANDERZEE, WAM
    LEAN, JS
    RYAN, SJ
    OPHTHALMOLOGICA, 1985, 190 (03) : 186 - 187
  • [22] ABSENCE OF PROLIFERATIVE VITREORETINOPATHY (PVR) IN INFEROTEMPORAL JUVENILE DIALYSIS (ITJD)
    JIMENEZSIERRA, J
    PADILLAAILHAUD, A
    ARDILA, J
    SANTOS, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 957 - 957
  • [23] EXPRESSION OF ACIDIC FIBROBLAST GROWTH-FACTOR (AFGF) IN A NOVEL MODEL OF PROLIFERATIVE VITREORETINOPATHY (PVR)
    ROBERTSON, JE
    ANDRESEVIC, J
    KAY, G
    HOLMES, DL
    CHEN, JC
    PLANCK, SR
    ROSENBAUM, JT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 1299 - 1299
  • [24] Proliferative vitreoretinopathy (PVR) surgery: Scar Wars Five steps to successful treatment of PVR detachment
    Priglinger, S. G.
    Siedlecki, J.
    Hattenbach, L. -O.
    Grisanti, S.
    OPHTHALMOLOGE, 2021, 118 (01): : 18 - 23
  • [25] Development of HC-HA/PTX3 as a Biologic for Proliferative Vitreoretinopathy (PVR) Treatment
    He, Hua
    Kuriyan, Ajay E.
    Arrieta, Esdras
    Mahabole, Megha
    Zhang, Yuan
    Hamlin, Kristy
    Graham, Victoria
    Parel, Jean-Marie A.
    Flynn, Harry W.
    Tseng, Scheffer C. G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [26] Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study
    Begum, Ghazala
    O'Neill, Jenna
    Chaudhary, Rishika
    Blachford, Karen
    Snead, David R. J.
    Berry, Martin
    Scott, Robert A. H.
    Logan, Ann
    Blanch, Richard J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (12) : 4929 - 4936
  • [27] Antiproliferative effect of mitomycin C in the treatment of experimental proliferative vitreoretinopathy (PVR)
    Chen, SN
    Chao, AN
    Ho, CL
    Lin, SM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S947 - S947
  • [28] SU9518 Inhibits Proliferative Vitreoretinopathy (PVR) in a Rabbit Model
    Velez, G.
    Kazlauskas, A.
    Young, M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [29] The role of matrix metalloproteinases (MMPs) in proliferative vitreoretinopathy (PVR) - A prospective study
    Kon, CH
    Occleston, NL
    Daniels, JT
    Charteris, DG
    Aylward, GW
    Khaw, PT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 5467 - 5467
  • [30] Chronobiology of proliferative vitreoretinopathy (PVR). A cytological study of 133 vitreous samples
    Martin, F
    Saornil, MA
    de la Rua, ER
    Mayo, A
    Fernandez, N
    Aragon, J
    Pastor, JC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1288 - U1288